Experience

Charlie Kim

    • ORIC Pharmaceuticals - $138 Million IPO 


    • Zentalis Pharmaceuticals - $190 Million IPO 


    • Uber Technologies $8.1 Billion IPO 


    • Fangdd $78 Million – IPO 


    • Vir Biotechnology - $143 Million IPO 


    • EHang Holdings - $40 Million IPO 


    • Medallia - $374 Million IPO 


    • Livongo Health - $409 Million IPO 


    • Health Catalyst - $209 Million IPO 


    • Allogene Therapeutics – $372.6 Million IPO 


    • Gossamer Bio – $317 Million IPO 


    • ShockWave Medical – $111 Million IPO 


    • Jazz Pharmaceuticals in $314.4 million Offering 


    • Cooley's Capital Markets Leadership Continues through 1H 2014 


    • Receptos, Inc. Initial Public Offering 


    • Crinetics Pharmaceuticals – $117 Million IPO 


    • Eidos Therapeutics – $122 Million IPO 


    • Neon Therapeutics – $100 Million IPO 


    • Tricida – $256 Million IPO 


    • Aridis – $26 Million IPO 


    • Gritstone Oncology – $100 Million IPO 


    • Aerohive Networks $75 Million IPO 


    • TriVascular Initial Public Offering 


    • Vital Therapies Initial Public Offering 


    • Kite Pharma $146 Million Initial Public Offering 


    • Minerva Neurosciences $32.7 Million IPO 


    • Immune Design $63 Million Initial Public Offering 


    • Otonomy $100 Million IPO 


    • Demira Prices $125 Million IPO 


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • HealthEquity $146 Million Initial Public Offering 


    • Ascendis Pharma closes $124 million IPO 


    • TRACON Pharmaceuticals Completes Initial Public Offering 


    • Cidara Completes Initial Public Offering  


    • Apigee Completes Initial Public Offering 


    • Invitae Completes $117 Million Initial Public Offering  


    • Advaxis – $30 Million Registered Direct Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • MINDBODY Completes $100 Million IPO 


    • Ooma Prices $65 Million IPO 


    • NantKwest IPO - $238 Million IPO 


    • ProNAi Therapeutics - $158 Million IPO 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Gemphire Therapeutics – $30 Million IPO 


    • Ionis Pharmaceuticals Completes Rule 144A Offering of $500 Million of Convertible Senior Notes 


    • Jazz Pharmaceuticals – $575 Million Exchangeable Senior Note Offering 


    • MINDBODY Completes $100 Million IPO 


    • NantKwest – $238 Million IPO 


    • ProNAi – $158 Million IPO 


    • Verona – $80 Million IPO 


    • Zealand Pharma – $89 Million IPO 


    • Zymeworks – $58.5 Million IPO 


    • Sutro Biopharma – $85 Million IPO 


    • Guardant Health – $273.1 Million IPO 


    • Seattle Genetics: $552 Million Follow-On 


    • Ionis Pharmaceuticals Completes Rule 144A Offering $500 Million of Convertible Senior Notes 


    • FireEye Completes 144A Private Placement of $920 Million Convertible Senior Notes 


    • Tableau Software – $292 Million IPO and Follow-On Offerings 


    • Five Prime Therapeutics IPO 


    • Amedica Initial Public Offering 


    • Castlight Health's $204 Million IPO 


    • Akero Therapeutics - $106 Million IPO 


    • 10X Genomics – $449 Million IPO  


    • IGM Biosciences – $201 Million IPO  


    • Exagen Diagnostics – $58 Million IPO  


    • Phathom Pharmaceuticals - $209 Million IPO 


    • 89bio – $98 Million IPO 


    • Insys Therapeutics IPO 


    • Reata Pharmaceuticals – $505 Million Follow-On Offering 


    • Pliant Therapeutics - $166 Million IPO 


    • The Underwriters On Guardant Health's $1.1 Billion Follow-On Offering 


    • The Underwriters On Livongo Health's $550 Million Convertible Senior Notes 


    • Applied Molecular Transport - $177 Million IPO 


    • Avidity Biosciences - $289 Million IPO 


    • Vaxcyte - $288 Milion IPO 


    • Poseida Therapeutics – $224 Million IPO